van der Wurff Inge S M, Meyer Barbara J, de Groot Renate H M
Welten Institute, Research Centre for Learning, Teaching, and Technology, Open University of The Netherlands, 6419 AT Heerlen, The Netherlands.
School of Medicine, University of Wollongong, Wollongong, NSW 2522, Australia.
Nutrients. 2017 May 10;9(5):474. doi: 10.3390/nu9050474.
The influence of -3 long-chain polyunsaturated fatty acids (-3 LCPUFA) supplementation on health outcomes has been studied extensively with randomized controlled trials (RCT). In many research fields, difficulties with recruitment, adherence and high drop-out rates have been reported. However, what is unknown is how common these problems are in -3 LCPUFA supplementation studies in children and adolescents. Therefore, this paper will review -3 LCPUFA supplementation studies in children and adolescents with regard to recruitment, adherence and drop-out rates.
The Web of Science, PubMed and Ovid databases were searched for papers reporting on RCT supplementing children and adolescents (2-18 years) with a form of -3 LCPUFA (or placebo) for at least four weeks. As a proxy for abiding to CONSORT guidelines, we noted whether manuscripts provided a flow-chart and provided dates defining the period of recruitment and follow-up.
Ninety manuscripts (reporting on 75 studies) met the inclusion criteria. The majority of the studies did not abide by the CONSORT guidelines: 55% did not provide a flow-chart, while 70% did not provide dates. The majority of studies provided minimal details about the recruitment process. Only 25 of the 75 studies reported an adherence rate which was on average 85%. Sixty-five of the 75 studies included drop-out rates which were on average 17%.
Less than half of the included studies abided by the CONSORT guidelines (45% included a flow chart, while 30% reported dates). Problems with recruitment and drop-out seem to be common in -3 LCPUFA supplementation trials in children and adolescents. However, reporting about recruitment, adherence and dropout rates was very heterogeneous and minimal in the included studies. Some techniques to improve recruitment, adherence and dropout rates were identified from the literature, however these techniques may need to be tailored to -3 LCPUFA supplementation studies in children and adolescents.
-3长链多不饱和脂肪酸(-3 LCPUFA)补充剂对健康结果的影响已通过随机对照试验(RCT)进行了广泛研究。在许多研究领域,都报告了招募、依从性方面的困难以及高辍学率。然而,在儿童和青少年-3 LCPUFA补充剂研究中,这些问题有多普遍尚不清楚。因此,本文将回顾儿童和青少年-3 LCPUFA补充剂研究在招募、依从性和辍学率方面的情况。
在科学网、PubMed和Ovid数据库中搜索报告对2至18岁儿童和青少年补充某种形式的-3 LCPUFA(或安慰剂)至少四周的随机对照试验的论文。作为遵守CONSORT指南的替代指标,我们记录了手稿是否提供了流程图,并提供了定义招募期和随访期的日期。
90篇手稿(报告75项研究)符合纳入标准。大多数研究未遵守CONSORT指南:55%未提供流程图,70%未提供日期。大多数研究提供的招募过程细节极少。75项研究中只有25项报告了依从率,平均为85%。75项研究中有65项纳入了辍学率,平均为17%。
纳入研究中不到一半遵守了CONSORT指南(45%包括流程图,30%报告了日期)。在儿童和青少年-3 LCPUFA补充剂试验中,招募和辍学问题似乎很常见。然而,在所纳入的研究中,关于招募、依从性和辍学率的报告非常不一致且极少。从文献中确定了一些提高招募、依从性和辍学率的技术,然而这些技术可能需要针对儿童和青少年-3 LCPUFA补充剂研究进行调整。